Skip to main content

Table 3 mRNA levels.

From: Expression of ADAMs and Their Inhibitors in Sputum from Patients with Asthma

 

Patients with asthma

Control subjects

ADAM-8

0.396 ± 0.042a

0.080 ±0.007

ADAM-9

0.677 ± 0.018a

0.617 ±0.013

ADAM-10

0.497 ± 0.016

0.547 ± 0.015

ADAM-12

0.145 ±0.012a

0.090 ±0.011

ADAM-15

0.684 ±0.019

0.637 ± 0.022

ADAM-17

1.127 ± 0.024

1.113 ± 0.026

ADAMTS-1

0.184 ±0.021a

0.273 ±0.023

ADAMTS-15

0.188 ± 0.025a

0.522 ±0.029

TIMP-1

0.522 ± 0.037a

0.270 ±0.017

TIMP-3

0.425 ± 0.047a

0.150 ±0.018

RECK

0.457 ± 0.030a

0.644 ± 0.035

  1. mRNA levels were determined in asthmatic and control samples by semiquantitative RT-PCR and normalized to 28S rRNA. Data are expressed in arbitrary units as mean ± SEM. aP < 0.05 vs. control subjects.